Business Context and Reporting Period
This Form 8-K filing by American Realty Capital Healthcare Trust II, Inc. (the "Company") reports significant changes in executive leadership effective March 22, 2014. The report was filed on March 27, 2014. The Company is a Maryland corporation focused on healthcare real estate assets.
Key Financial Metrics
The filing text does not provide specific financial data, including revenue, profit, cash flow, margins, debt, or liquidity metrics. This report is strictly limited to corporate governance and personnel changes.
Material Changes
The following personnel changes were effective March 22, 2014:
- Resignations: Nicholas Radesca resigned as interim Chief Financial Officer (CFO). Edward M. Weil, Jr. resigned as Chief Operating Officer (COO). Peter M. Budko resigned as Executive Vice President.
- Continued Roles: Edward M. Weil, Jr. remains an officer serving as President, Treasurer, and Secretary.
- Appointments: Edward F. Lange Jr. was appointed as the new CFO and COO. Nicholas S. Schorsch was appointed as Executive Chairman of the Board.
- Reason for Departure: The resignations of Mr. Radesca, Mr. Weil, and Mr. Budko were not due to any disagreement with the Company.
Management Commentary and Background
Edward F. Lange Jr. (New CFO/COO): Mr. Lange brings 30 years of executive leadership experience in real estate finance and healthcare. He previously served as CEO of HRC Investors Corp. (2013), CFO of Americold Realty Trust (2011-2012), and CFO/COO of BRE Properties, Inc. (2000-2010). He has been serving as CFO/COO of the Company's advisor and property manager since February 2014.
Nicholas S. Schorsch (New Executive Chairman): Mr. Schorsch has extensive experience in real estate investment and private equity, having founded American Financial Realty Trust (AFRT) and executed over 1,000 acquisitions with approximately $5 billion in transactional value. He has held leadership roles across multiple American Realty Capital entities, including ARC HT, ARCP, and ARC Global.
Risks and Contingencies: The filing states there are no related party transactions involving Mr. Lange reportable under Item 404(a) of Regulation S-K. No other risks or contingencies are disclosed in this specific report.
Investor Verification Checklist
- Verify the transition plan for financial reporting and operational oversight following the departure of the interim CFO and COO.
- Confirm the specific compensation arrangements for the newly appointed CFO/COO, Edward F. Lange Jr., in subsequent filings.
- Review the Company's most recent 10-Q or 10-K for financial performance data, as this 8-K contains no financial metrics.
- Monitor future filings for any further changes to the executive team or board composition.